FI44909C - Menetelmä tulehdusta estävän alfa-(aroyyli-3-indolyyli)-alifaattisen h apon N-substituoidun amidin valmistamiseksi - Google Patents

Menetelmä tulehdusta estävän alfa-(aroyyli-3-indolyyli)-alifaattisen h apon N-substituoidun amidin valmistamiseksi

Info

Publication number
FI44909C
FI44909C FI640949A FI94964A FI44909C FI 44909 C FI44909 C FI 44909C FI 640949 A FI640949 A FI 640949A FI 94964 A FI94964 A FI 94964A FI 44909 C FI44909 C FI 44909C
Authority
FI
Finland
Prior art keywords
aroyl
indolyl
inflammation
alpha
preventing
Prior art date
Application number
FI640949A
Other languages
English (en)
Swedish (sv)
Other versions
FI44909B (fi
Inventor
Shen Tsung-Ying
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US276986A external-priority patent/US3285908A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI44909B publication Critical patent/FI44909B/fi
Application granted granted Critical
Publication of FI44909C publication Critical patent/FI44909C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/281-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Motor Or Generator Current Collectors (AREA)
FI640949A 1963-04-30 1964-04-30 Menetelmä tulehdusta estävän alfa-(aroyyli-3-indolyyli)-alifaattisen h apon N-substituoidun amidin valmistamiseksi FI44909C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US276986A US3285908A (en) 1963-04-30 1963-04-30 Indolyl acid amides
US331075A US3336194A (en) 1963-04-30 1963-11-18 Indolyl acid amides

Publications (2)

Publication Number Publication Date
FI44909B FI44909B (fi) 1971-11-01
FI44909C true FI44909C (fi) 1972-02-10

Family

ID=26958249

Family Applications (1)

Application Number Title Priority Date Filing Date
FI640949A FI44909C (fi) 1963-04-30 1964-04-30 Menetelmä tulehdusta estävän alfa-(aroyyli-3-indolyyli)-alifaattisen h apon N-substituoidun amidin valmistamiseksi

Country Status (11)

Country Link
US (1) US3336194A (fi)
BE (1) BE647413A (fi)
BR (1) BR6458809D0 (fi)
CH (2) CH462169A (fi)
DK (2) DK135347B (fi)
FI (1) FI44909C (fi)
FR (1) FR1567853A (fi)
GB (1) GB1058984A (fi)
NL (1) NL6404781A (fi)
NO (1) NO118746B (fi)
SE (1) SE301320B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3669960A (en) * 1968-09-10 1972-06-13 Sumitomo Chemical Co Novel amides of 3-indolylacetic acid
DE2223051C2 (de) * 1972-05-09 1983-02-03 Farmades S.p.A., Rom Monohydrat des d(+)-Glucosamids der 1-(p-Chlorbenzoyl)2-methyl-5-methoxy-indolyl-3-essigsäure, Verfahren zu seiner Herstellung und pharmazeutische Zubereitung
DE2413125C2 (de) * 1974-03-15 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Indolylacetylaminosäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneipräparate
PT72878B (en) * 1980-04-24 1983-03-29 Merck & Co Inc Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
US4585784A (en) * 1983-01-26 1986-04-29 Mcneilab, Inc. Pyrrole-2-acetylamino acid derivative compounds
US4902708A (en) * 1985-12-31 1990-02-20 Biomeasure, Inc. CCK antagonists
US5532237A (en) * 1995-02-15 1996-07-02 Merck Frosst Canada, Inc. Indole derivatives with affinity for the cannabinoid receptor
BR9917001A (pt) * 1999-01-07 2001-11-13 Univ Vanderbilt Conversão de compostos de inibição de cox quenão são inibidores seletivos de cox-2 em derivadosque são inibidores seletivos de cox-2
US6207700B1 (en) 1999-01-07 2001-03-27 Vanderbilt University Amide derivatives for antiangiogenic and/or antitumorigenic use
US6762182B1 (en) 1999-01-07 2004-07-13 Vanderbilt University Converting cox inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors
US6306890B1 (en) 1999-08-30 2001-10-23 Vanderbilt University Esters derived from indolealkanols and novel amides derived from indolealkylamides that are selective COX-2 inhibitors
US7135495B2 (en) * 2000-03-09 2006-11-14 Ono Pharmaceutical Co., Ltd. Indole derivatives
JPWO2003022814A1 (ja) * 2001-09-07 2004-12-24 小野薬品工業株式会社 インドール誘導体化合物
EP1610776A4 (en) * 2003-03-27 2007-03-28 Merck & Co Inc OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF OCCULAR HYPERTONIA
EP1638612A4 (en) * 2003-06-25 2010-09-29 Univ Vanderbilt COX-2-MADE DISPLAY AGENTS
CA2563617A1 (en) * 2004-04-20 2005-11-03 Rnd Pharmaceuticals Pharmaceutical compositions and methods of use of lipophilic, silicon-substituted, cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs and derivatives
CA2562783A1 (en) * 2004-04-26 2005-12-01 Vanderbilt University Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity
BRPI0606515A2 (pt) * 2005-01-04 2009-06-30 Novartis Ag estrutura de raios x de fpps humana e uso para selecionar compostos de ligação de fpps
EP2040699A4 (en) 2006-06-19 2013-03-13 Vanderbilt University Medical Ct METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND THERAPEUTIC TARGETING OF COX-2
EP3078374B1 (en) 2011-10-17 2019-06-19 Vanderbilt University Indomethacin analogs for the treatment of castrate-resistant prostate cancer

Also Published As

Publication number Publication date
FI44909B (fi) 1971-11-01
DK135347C (fi) 1977-09-26
GB1058984A (en) 1967-02-15
CH460779A (de) 1968-08-15
US3336194A (en) 1967-08-15
BR6458809D0 (pt) 1973-07-19
DK135347B (da) 1977-04-12
BE647413A (fi) 1964-10-30
NO118746B (fi) 1970-02-09
DK119006B (da) 1970-11-02
SE301320B (fi) 1968-06-04
CH462169A (de) 1968-09-15
FR1567853A (fi) 1969-05-23
NL6404781A (fi) 1964-11-02

Similar Documents

Publication Publication Date Title
FI44909C (fi) Menetelmä tulehdusta estävän alfa-(aroyyli-3-indolyyli)-alifaattisen h apon N-substituoidun amidin valmistamiseksi
FI45446C (fi) Menetelmä uusien fysiologisesti vaikuttavien N-substituoitujen laktaam ien valmistamiseksi
FI44648C (fi) Menetelmä elektreettien valmistamiseksi
FI41394C (fi) Menetelmä terapeuttisesti vaikuttavien N-substituoitujen I-aminoindaani-johdannaisten valmistamiseksi
DK127979B (da) Analogifremgangsmåde til fremstilling af N-(tert.aminoalkyl)- amidderivater eller syreadditionssalte deraf.
SE407798B (sv) Forfarande for syntetisering av aminosyraamider av dopamin
CH449650A (fr) Procédé de préparation des N-(tertiaire-aminoalkyl)-méthylène-dioxybenzamides
FI48833C (fi) Menetelmä terapeuttisesti käytettävien meripihkahappoimidien valmistam iseksi.
DK123764B (da) Analogifremgangsmåde til fremstilling af syreamider.
DK117077B (da) Analogifremgangsmåde til fremstilling af substituerede phenyleddikesyreamider.
OA00117A (fr) Procédé de préparation de nouveaux N-(w-guanidino-alkyl)-azaspiro-alcanes.
DK121853B (da) Analogifremgangsmåde til fremstilling af diphenoxyeddikesyreamider.
SE327405B (no) Förfarande för framställning av nya iminodibensylderivat
CH461526A (de) Verfahren zur Herstellung von heterocyclischen Aminderivaten
DK105343C (da) Fremgangsmåde til fremstilling af α-hydroxyethylderivater af 1-methyl-dihydro-D-lysergsyreamid.
FI50424C (fi) Menetelmä 6-aminopenisillaanihapon N-asyloimiseksi
CA666572A (en) Process for the preparation of nitro derivatives from cyclic amides
BE755701A (fr) Procede de preparation de n-(4-chloro-phenylthiomethyl)- phtalimide
CA668080A (en) Process for making acyl amides of amino acid salts
FI50528C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten D-6-metyyli-8-ergoli n(I)yylietikkahappoamidien valmistamiseksi
DK121163B (da) Analogifremgangsmåde til fremstilling af substituerede phenyleddikesyreamider.
FI50529C (fi) Menetelmä farmakologisesti käyttökelpoisten D-6-metyyli-8-ergolin(I)yy lietikkahappoamidien valmistamiseksi
FI33269A (fi) Förfarande för framställning av alfa-amino-beeta-oxi-karbonsyraamider
FI37510A (fi) Förfarande för framställning av fenylalanin-derivat
CA685228A (en) Process and apparatus for drying of graunulated polyamides